uniQure(QURE)
4.56 -0.19 -4.0%
| 今开：4.77 | 昨收：4.75 |
| 最高：4.78 | 最低：4.48 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.18142534E8 |
uniQure的热门讨论
持股变动年度报告
uniQure(QURE)02-07 06:35
$uniQure(QURE)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000112 Size: 6 KB 网页链接查看全文
员工持股计划
uniQure(QURE)02-28 21:35
$uniQure(QURE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001558370-24-001917 Act: 33 Size: 169 KB 网页链接查看全文
持股变动声明
uniQure(QURE)02-29 05:45
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000191 Size: 5 KB 网页链接查看全文
超过5%股东持股披露
uniQure(QURE)02-14 05:35
$uniQure(QURE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001482 Act: 34 Size: 64 KB 网页链接查看全文
持股变动声明
uniQure(QURE)03-06 06:25
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203 Size: 7 KB 网页链接查看全文
当期报告
uniQure(QURE)04-12 19:05
$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994 Act: 34 Size: 145 KB 网页链接查看全文
当期报告
uniQure(QURE)02-28 21:05
$uniQure(QURE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-028484 Act: 34 Size: 328 KB 网页链接查看全文
持股变动声明
uniQure(QURE)03-06 06:15
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201 Size: 7 KB 网页链接查看全文
超过5%股东持股披露「修订」
uniQure(QURE)02-09 23:15
$uniQure(QURE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001582 Act: 34 Size: 8 KB 网页链接查看全文
证券出售报告
uniQure(QURE)02-27 05:35
$uniQure(QURE)$ 144 Report of proposed sale of securities Accession Number: 0001973379-24-000061 Act: 33 Size: 4 KB 网页链接查看全文
uniQure的最新讨论
疑夕2015-05-04 23:34
$Celladon Corporation(CLDN)$ 失败后，整个基因疗法二级市场形成恐慌，$uniQure(QURE)$ $Avalanche Biotechnologies(AAVL)$ $BLUEBIRD BIO INC(BLUE)$ $Applied Genetic Technologies(AGTC)$ $SPARK THERAPEUTICS INC(ONCE)$ 全线坍塌，个人仍然看好这项技术，大部分遗传病的希望都在这。查看全文
割资本主义羊毛2015-04-20 04:01
If $Celladon Corporation(CLDN)$ fails $uniQure(QURE)$ is differentiated, If CLDN succeeds ...its further validation for QURE...@疑夕查看全文
![[为什么]](http://js.xueqiu.com/ugc/images/face/emoji_14_doubt.png?v=1 "[为什么]"){kind=small}
小熊投资2015-04-06 15:12
史上最全的美国基因治疗投资报告！
2015-03-16
11:21:50来源：光大证券
0美国基因治疗生物技术医疗投资
当前美国生物技术领域投资的热点是癌症免疫疗法、基因测序和基因治疗。其中前两项在国内相关的报告中已经有详细的介绍，但基因治疗行业动态却鲜有跟踪。本报告简单介绍基因治疗...查看全文
He_is_MAD2015-04-03 11:54
$uniQure(QURE)$ 2014年2月上市，目前市值4.15亿US，Glybera12年欧洲获批，15年才可能进行商业化，主要治疗LPLD，每年在欧洲也就200-300人可以接受治疗。整个疗程超过100万EU，国内这种公司很少，深圳那家乱七八糟。查看全文
淡投2015-02-14 06:23
13G filed by Forbion: 1,865,494 share of $uniQure(QURE)$ 网页链接
Forbion is also an early investor in $BLUEBIRD BIO INC(BLUE)$查看全文
淡投2015-02-12 02:10
$uniQure(QURE)$ has multiple clinical CNS pipeline candidates (or rights to in-licence) to including Parkinson's and Sanfilippo B. It also has exclusive collaboration with 4D molecular therapeutics to develop next-gen AAV vectors targeting CNS (and liver)查看全文
uniQure的新闻
H.C. Wainwright：重申uniQure(QURE.US)“买入”评级 予目标价90美元
智通财经APP获悉，H.C. Wainwright分析师Patrick Trucchio重申uniQure(QURE.US)“买入”评级，并给予目标价90美元。在辉瑞公司(PFE.US)公布了基因疗法fidanacogene elaparvovec用于治疗中重度至重度B型血友病的3期BENEGENE-2试验的主要... 网页链接
uniQure的公告
股东委托书协议
$uniQure(QURE)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005525 Act: 34 Size: 4 MB 网页链接
其他
$uniQure(QURE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005526 Act: 34 Size: 538 KB 网页链接
其他
$uniQure(QURE)$ PRE 14A Other preliminary proxy statements Accession Number: 0001558370-24-004996 Act: 34 Size: 4 MB 网页链接
当期报告
$uniQure(QURE)$ 8-K Current report, item 5.02 Accession Number: 0001558370-24-004994 Act: 34 Size: 145 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000203 Size: 7 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000199 Size: 7 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000201 Size: 7 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000197 Size: 7 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000195 Size: 7 KB 网页链接
持股变动声明
$uniQure(QURE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000904454-24-000191 Size: 5 KB 网页链接